US 10981986
Fusions of antibodies to CD38 and attenuated interferon alpha
granted A61KA61K38/00A61K47/642
Quick answer
US patent 10981986 (Fusions of antibodies to CD38 and attenuated interferon alpha) held by TEVA PHARMACEUTICALS AUSTRALIA PTY LTD expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICALS AUSTRALIA PTY LTD
- Grant date
- Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K38/00, A61K47/642, A61P, A61P35/00